Screening for colorectal cancer

New England Journal of Medicine

Volumn 362, Issue 1, 2010, Pages 84-85

  Guittet, Lydia ^a   Launoy, Guy ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; HUMAN; LETTER; OCCULT BLOOD TEST; PATIENT PARTICIPATION; PRIORITY JOURNAL; ADENOMA; COLORECTAL TUMOR; IMMUNOCHEMISTRY; MASS SCREENING; METHODOLOGY; NOTE; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

ADENOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 74049108981     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0910682     Document Type: Letter

References (5)

1. Lieberman DA. Screening for colorectal cancer. N Engl J Med 2009;361:1179-87.
2. Guittet L, Bouvier V, Mariotte N, et al. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125:1127-33.
3. Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 2009;69:1288-95.
4. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2009 August 10 (Epub ahead of print).
5. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult testing at different cut-off levels. Br J Cancer 2009;100:1103-10.